Market Overview:
The global chlorinated pharmaceutical solvent market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for liniment, injection, and oral medication applications across the globe. Additionally, rising awareness about the benefits of using chlorinated pharmaceutical solvents is also propelling the market growth. However, stringent regulatory norms regarding environmental safety are likely to hamper market growth in certain regions over the forecast period. Based on type, carbon tetrachloride held a dominant position in 2017 and is expected to maintain its dominance throughout the forecast period. This can be attributed to its high volatility and flammability which makes it an ideal choice for various applications such as liniment and injection solutions.
Product Definition:
Chlorinated Pharmaceutical Solvent is a type of solvent that has been used in the pharmaceutical industry for many years. It is important because it helps to dissolve substances and make them more soluble so they can be administered to patients.
Carbon Tetrachloride:
Carbon tetrachloride is a colorless, tasteless, odorless liquid that is soluble in water. It has a strong smell when it comes into contact with air. The substance is considered to be highly toxic and can cause instant death on direct exposure to the skin or if it enters the body through inhalation route.
The product was first manufactured by Union Carbide in 1941 as an intermediate for manufacturing trichloroethylene (TCE).
Dichloromethane:
Dichloromethane (DCM) is a colorless and highly flammable organic compound. DCM is produced by the reaction of hydrogen chloride and methanol. It has an aroma similar to bleach and tastes slightly sweet.
Application Insights:
In terms of application, the global market is categorized into liniment, injection, oral medication, and others. The liniments segment dominated the overall application category in 2017 owing to its high usage rate across various applications such as ointments and lotions. In addition, it finds extensive use as a solvent for making solutions or suspensions that are used for external analgesia or topical anesthetic gels that are applied to the skin.
The injection segment is expected to witness significant growth over the forecast period due to increasing product demand from pharmaceutical manufacturers for preparing injections by using it as a medium where proteins can be dissolved efficiently. It also has wide applications in formulating syringes and insulin pens among others owing to its properties such as being sterile & colorless which makes it suitable for medical purposes other than pain management & anesthesia induction respectively.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a growth rate of 3.6% over the forecast period, which can be attributed to increasing R&D activities and rising healthcare spending in U.S. In addition, stringent regulations by U.S Environmental Protection Agency (EPA) and Food & Drug Administration (FDA) for manufacturing and processing pharmaceutical solvents are anticipated to drive demand for CCl3OC1 products over the forecast period in North America as well as other regions globally.
Asia Pacific is projected to exhibit fastest growth during the forecast period owing to rapid economic development coupled with increased spending on healthcare infrastructure development in emerging countries such as China, India, South Korea among others are expected boost market growth during the estimated time-frame of 2018 through 2030 The Middle East & Africa region was valued at USD X millionin 2017.
Growth Factors:
- Increasing demand for Chlorinated Pharmaceutical Solvent in the pharmaceutical and biotechnology industries for the production of various drugs and vaccines.
- Growing research and development activities in the field of new drug discovery, which is expected to fuel the demand for Chlorinated Pharmaceutical Solvent in coming years.
- Rising awareness about benefits of using Chlorinated Pharmaceutical Solvent over other solvents among pharmaceutical manufacturers, which is likely to boost market growth during forecast period.
- Technological advancements in chlorination process that has resulted into development of more efficient and environment-friendly solvents, is projected to propel market growth over next few years. 5) Expansion of global healthcare infrastructure coupled with increasing investments by key players are some other factors anticipated to drive growth of chlorinated pharmaceutical solvent market during forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Chlorinated Pharmaceutical Solvent Market Research Report
By Type
Carbon Tetrachloride, Dichloromethane, Others
By Application
Liniment, Injection, Oral Medication, Others
By Companies
AkzoNobel, DOW, Ineos Oxide, Solvay, Shin-Etsu Chemical, Occidental Petroleum, Tokuyama, Ercros, Kem One
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Chlorinated Pharmaceutical Solvent Market Report Segments:
The global Chlorinated Pharmaceutical Solvent market is segmented on the basis of:
Types
Carbon Tetrachloride, Dichloromethane, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Liniment, Injection, Oral Medication, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AkzoNobel
- DOW
- Ineos Oxide
- Solvay
- Shin-Etsu Chemical
- Occidental Petroleum
- Tokuyama
- Ercros
- Kem One
Highlights of The Chlorinated Pharmaceutical Solvent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Carbon Tetrachloride
- Dichloromethane
- Others
- By Application:
- Liniment
- Injection
- Oral Medication
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chlorinated Pharmaceutical Solvent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chlorinated pharmaceutical solvents are a type of solvent that is made from chlorinated hydrocarbons. These solvents are used in many different types of products, including medications and cleaning products.
Some of the key players operating in the chlorinated pharmaceutical solvent market are AkzoNobel, DOW, Ineos Oxide, Solvay, Shin-Etsu Chemical, Occidental Petroleum, Tokuyama, Ercros, Kem One.
The chlorinated pharmaceutical solvent market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chlorinated Pharmaceutical Solvent Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Chlorinated Pharmaceutical Solvent Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Chlorinated Pharmaceutical Solvent Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Chlorinated Pharmaceutical Solvent Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Chlorinated Pharmaceutical Solvent Market Size & Forecast, 2018-2028 4.5.1 Chlorinated Pharmaceutical Solvent Market Size and Y-o-Y Growth 4.5.2 Chlorinated Pharmaceutical Solvent Market Absolute $ Opportunity
Chapter 5 Global Chlorinated Pharmaceutical Solvent Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chlorinated Pharmaceutical Solvent Market Size Forecast by Type
5.2.1 Carbon Tetrachloride
5.2.2 Dichloromethane
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chlorinated Pharmaceutical Solvent Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chlorinated Pharmaceutical Solvent Market Size Forecast by Applications
6.2.1 Liniment
6.2.2 Injection
6.2.3 Oral Medication
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chlorinated Pharmaceutical Solvent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chlorinated Pharmaceutical Solvent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chlorinated Pharmaceutical Solvent Analysis and Forecast
9.1 Introduction
9.2 North America Chlorinated Pharmaceutical Solvent Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chlorinated Pharmaceutical Solvent Market Size Forecast by Type
9.6.1 Carbon Tetrachloride
9.6.2 Dichloromethane
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chlorinated Pharmaceutical Solvent Market Size Forecast by Applications
9.10.1 Liniment
9.10.2 Injection
9.10.3 Oral Medication
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chlorinated Pharmaceutical Solvent Analysis and Forecast
10.1 Introduction
10.2 Europe Chlorinated Pharmaceutical Solvent Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chlorinated Pharmaceutical Solvent Market Size Forecast by Type
10.6.1 Carbon Tetrachloride
10.6.2 Dichloromethane
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chlorinated Pharmaceutical Solvent Market Size Forecast by Applications
10.10.1 Liniment
10.10.2 Injection
10.10.3 Oral Medication
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chlorinated Pharmaceutical Solvent Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chlorinated Pharmaceutical Solvent Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chlorinated Pharmaceutical Solvent Market Size Forecast by Type
11.6.1 Carbon Tetrachloride
11.6.2 Dichloromethane
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chlorinated Pharmaceutical Solvent Market Size Forecast by Applications
11.10.1 Liniment
11.10.2 Injection
11.10.3 Oral Medication
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chlorinated Pharmaceutical Solvent Analysis and Forecast
12.1 Introduction
12.2 Latin America Chlorinated Pharmaceutical Solvent Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chlorinated Pharmaceutical Solvent Market Size Forecast by Type
12.6.1 Carbon Tetrachloride
12.6.2 Dichloromethane
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chlorinated Pharmaceutical Solvent Market Size Forecast by Applications
12.10.1 Liniment
12.10.2 Injection
12.10.3 Oral Medication
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chlorinated Pharmaceutical Solvent Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chlorinated Pharmaceutical Solvent Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chlorinated Pharmaceutical Solvent Market Size Forecast by Type
13.6.1 Carbon Tetrachloride
13.6.2 Dichloromethane
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chlorinated Pharmaceutical Solvent Market Size Forecast by Applications
13.10.1 Liniment
13.10.2 Injection
13.10.3 Oral Medication
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chlorinated Pharmaceutical Solvent Market: Competitive Dashboard
14.2 Global Chlorinated Pharmaceutical Solvent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AkzoNobel
14.3.2 DOW
14.3.3 Ineos Oxide
14.3.4 Solvay
14.3.5 Shin-Etsu Chemical
14.3.6 Occidental Petroleum
14.3.7 Tokuyama
14.3.8 Ercros
14.3.9 Kem One